This Week in Biotech Bulls & Breakthroughs (Apr 13 - Apr 19, 2026)

This week, This Week in Biotech Bulls & Breakthroughs examined the evolving landscape of biomanufacturing with Michael Heltzen of eXoZymes, exploring how engineered biology is reshaping production capabilities across the industry. The discussion centered on the practical challenges and opportunities in scaling biological manufacturing processes, from cost efficiency to regulatory pathways. As biotech companies increasingly look to move beyond traditional chemical synthesis, the conversation highlighted both the promise and the near-term hurdles facing next-generation manufacturing approaches.